Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
The decision to continue, modify, or cease treatment should be made collaboratively between patient and prescriber, weighing individual benefits against adverse effects whilst considering alternative weight management strategies
The best sources of the nutrient are fresh fruits and vegetables
DOI: 10.1056/NEJMoa1616011 [Google Scholar] Kaul S
US$ 23.75
US$ 29.51
US$ 27.86
US$ 28.14
US$ 23.95
US$ 21.36
US$ 23.06
US$ 27.01
US$ 26.14
US$ 21.68
